DEVELOPMENT OF A MEASURE OF QUALITY OF LIFE FOR CATS WITH DIABETES MELLITUS AND THEIR OWNERS: THE DIAQoL-pet
Presentation / Conference Contribution
Niessen, S. J. M., Powney, S. L., Guitian, J., Niessen, A., Pion, P., Shaw, J., & Church, D. B. DEVELOPMENT OF A MEASURE OF QUALITY OF LIFE FOR CATS WITH DIABETES MELLITUS AND THEIR OWNERS: THE DIAQoL-pet
All Outputs (190)
RISK FACTORS FOR EPILEPTIC SEIZURES IN DOGS WITH INTRACRANIAL NEOPLASIA
Presentation / Conference Contribution
Schwartz, M., Lamb, C. R., Brodbelt, D. C., & Volk, H. A. RISK FACTORS FOR EPILEPTIC SEIZURES IN DOGS WITH INTRACRANIAL NEOPLASIA
TREATMENT WITH AN ALPHA 2A ADRENORECEPTOR ANTAGONIST MODULATES HEPATIC INFLAMMATION, MARKEDLY REDUCES PORTAL PRESSURE, AND IMPROVES ARTERIAL PRESSURE AND HEPATIC BLOOD FLOW IN CIRRHOTIC RATS
Presentation / Conference Contribution
Sharma, V., Lee, K. C. L., Balasubramaniyan, V., Habtesion, A., Mehta, G., Davies, N., Jalan, R., & Mookerjee, R. P. TREATMENT WITH AN ALPHA 2A ADRENORECEPTOR ANTAGONIST MODULATES HEPATIC INFLAMMATION, MARKEDLY REDUCES PORTAL PRESSURE, AND IMPROVES ARTERIAL PRESSURE AND HEPATIC BLOOD FLOW IN CIRRHOTIC RATS
SURGICAL MANAGEMENT OF HYDROCEPHALUS BY VENTRICULOPERITONEAL SHUNT PLACEMENT IN DOGS
Presentation / Conference Contribution
Shihab, N. K., Davies, E., Kenny, P. J., Loderstedt, S., & Volk, H. A. SURGICAL MANAGEMENT OF HYDROCEPHALUS BY VENTRICULOPERITONEAL SHUNT PLACEMENT IN DOGS
IMMUNOHISTOCHEMICAL EXPRESSION OF CYCLOOXYGENASE (COX)-1 AND-2 ENZYMES IN FELINE CHRONIC KIDNEY DISEASE
Presentation / Conference Contribution
Suemanotham, N., Syme, H. M., Berhane, Y., Smith, K. C., & Elliott, J. IMMUNOHISTOCHEMICAL EXPRESSION OF CYCLOOXYGENASE (COX)-1 AND-2 ENZYMES IN FELINE CHRONIC KIDNEY DISEASE
MDX MICE SHOW CHANGES IN MUSCLE FIBER PROFILE NUMBER WITH AGE
Presentation / Conference Contribution
Terry, R. L., Hasan, N., & Wells, D. J. MDX MICE SHOW CHANGES IN MUSCLE FIBER PROFILE NUMBER WITH AGE
INCOMPLETE OSSIFICATION OF THE ATLAS IN 5 DOGS WITH CERVICAL SIGNS
Presentation / Conference Contribution
Warren-Smith, C. M. R., Kneissl, S., Benigni, L., Kenny, P. J., & Lamb, C. R. INCOMPLETE OSSIFICATION OF THE ATLAS IN 5 DOGS WITH CERVICAL SIGNS
IATROGENIC HYPOTHYROIDISM (IH) CONTRIBUTES TO THE DEVELOPMENT OF AZOTEMIA IN HYPERTHYROID CATS
Presentation / Conference Contribution
Williams, T. L., Elliott, J., & Syme, H. M. IATROGENIC HYPOTHYROIDISM (IH) CONTRIBUTES TO THE DEVELOPMENT OF AZOTEMIA IN HYPERTHYROID CATS
EVALUATION OF BONE MARROW MESENCHYMAL STEM CELL THERAPY FOR TENDON REGENERATION IN A LARGE ANIMAL MODEL
Presentation / Conference Contribution
Young, N. J., Dudhia, J., Goodship, A. E., & Smith, R. K. W. EVALUATION OF BONE MARROW MESENCHYMAL STEM CELL THERAPY FOR TENDON REGENERATION IN A LARGE ANIMAL MODEL
3d conformal radiation therapy for palliative treatment of canine nasal tumors
Presentation / Conference Contribution
Buchholz, J., Hagen, R., Leo, C., Ebling, A., Roos, M., Kaser-Hotz, B., & Bley, C. R. 3d conformal radiation therapy for palliative treatment of canine nasal tumors
THE EXPRESSION OF OXYTOCIN RECEPTOR, CPHOSPOLIPASE A(2) AND CYCLOOXYGENASE 2 IN THE CERVIX OF EWES DURING THE OESTROUS CYCLE
Presentation / Conference Contribution
Falchi, L., Perry, K., Khalid, M., & Scaramuzzi, R. J. THE EXPRESSION OF OXYTOCIN RECEPTOR, CPHOSPOLIPASE A(2) AND CYCLOOXYGENASE 2 IN THE CERVIX OF EWES DURING THE OESTROUS CYCLE
Adverse events associated with pericardiocentesis in dogs: 85 cases (1999-2006)
Presentation / Conference Contribution
Humm, K. R., Keenaghan-Clark, E. A., & Boag, A. K. Adverse events associated with pericardiocentesis in dogs: 85 cases (1999-2006)
Experimental Study of Bone Lengthening in Dogs by Means of Backscattered Scanning Electron Microscopy
Presentation / Conference Contribution
Lafuente, M. P., Franch, J., Durall, I., & Manzanares, C. Experimental Study of Bone Lengthening in Dogs by Means of Backscattered Scanning Electron Microscopy
PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
Presentation / Conference Contribution
Lees, P., Giraudel, J., Toutain, P. L., Pelligand, L., & King, J. N. PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
WHOLE GENOME MICROARRAY ANALYSIS OF MRSA ISOLATED FROM PETS AND THEIR IN-CONTACT HUMANS
Presentation / Conference Contribution
Loeffler, A., Pfeiffer, D. U., Lloyd, D. H., & Lindsay, J. A. WHOLE GENOME MICROARRAY ANALYSIS OF MRSA ISOLATED FROM PETS AND THEIR IN-CONTACT HUMANS
MT1-MMP IN HUMAN RHEUMATOID ARTHRITIS
Presentation / Conference Contribution
Miller, M. C., Manning, H. B., Jain, A., Troeberg, L., Dudhia, J., Essex, D., Sandison, A., Seiki, M., Nanchahal, J., Nagase, H., & Itoh, Y. MT1-MMP IN HUMAN RHEUMATOID ARTHRITIS
MUSCLE TARGETED GENE THERAPY FOR DIABETES MELLITUS: ROLE OF PROTEASOMAL DECAY IN MUTANT PROINSULIN PLASMID EFFICIENCY
Presentation / Conference Contribution
Niessen, S. J. M., Mahmoud, A., Arden, C., Brown, A., Campbell, S., Aldibbiat, A., Church, D. B., & Shaw, J. MUSCLE TARGETED GENE THERAPY FOR DIABETES MELLITUS: ROLE OF PROTEASOMAL DECAY IN MUTANT PROINSULIN PLASMID EFFICIENCY
ACCEPTANCE OF MUSCLE TARGETED GENE THERAPY FOR DIABETES MELLITUS AMONGST PATIENTS AT A DUTCH DIABETES CLINIC
Presentation / Conference Contribution
Niessen, S. J. M., Mahmoud, A., Niessen, Y., Groot, M. L., Heijster, J., Church, D. B., & Shaw, J. ACCEPTANCE OF MUSCLE TARGETED GENE THERAPY FOR DIABETES MELLITUS AMONGST PATIENTS AT A DUTCH DIABETES CLINIC
IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION
Presentation / Conference Contribution
Pelligand, L., King, J. N., Toutain, P. L., & Lees, P. IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION
APPLICATION OF STRAIN TO CO-CULTURES OF EQUINE TENDON FIBROBLASTS AND MESENCHYMAL STROMAL CELLS DECREASES TENASCIN-C AND COLLAGEN TYPE-V EXPRESSION
Presentation / Conference Contribution
Taylor, S., Smith, R. K. W., & Clegg, P. APPLICATION OF STRAIN TO CO-CULTURES OF EQUINE TENDON FIBROBLASTS AND MESENCHYMAL STROMAL CELLS DECREASES TENASCIN-C AND COLLAGEN TYPE-V EXPRESSION